Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CSP #594 - Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat

NCT02579096 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT02579096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02579096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CSP #594 - Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat
Lead sponsor
VA Office of Research and Development
Phase
Phase 4
Overall status
Completed
Start date
March 6, 2017
Completion date
April 15, 2021
Enrollment
950 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, gout